XML 61 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation (income) expense

The following table summarizes share-based compensation expense:

 

 

Year Ended December 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2021

 

Performance-based restricted stock units

 

$

3,282

 

 

$

541

 

 

$

549

 

Restricted stock awards and restricted stock units

 

 

6,523

 

 

 

6,703

 

 

 

5,451

 

Stock options

 

 

1,647

 

 

 

2,997

 

 

 

1,727

 

Share-based compensation expense before income tax

 

 

11,452

 

 

 

10,241

 

 

 

7,727

 

Income tax benefit(1)

 

 

(151

)

 

 

(117

)

 

 

(82

)

Share-based compensation expense, net of income tax

 

$

11,301

 

 

$

10,124

 

 

$

7,645

 

(1)
The income tax benefit amount for all periods primarily reflects the tax benefit associated with our Canadian-based employees. Refer to Note 18 – Income Taxes.
Summary of Activity of the Outstanding PUP Awards

The following table summarizes the activity of the outstanding PRSU awards:

 

 

Equity-Based
PRSUs

 

 

Liability-Based
PRSUs

 

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Balance at December 31, 2022

 

 

101,785

 

 

$

31.28

 

 

 

40,075

 

 

$

56.06

 

Granted(1)

 

 

191,883

 

 

$

36.48

 

 

 

 

 

$

 

Vested

 

 

 

 

$

 

 

 

(40,075

)

 

$

56.06

 

Forfeited(1)

 

 

(9,475

)

 

$

36.46

 

 

 

 

 

$

 

Balance at December 31, 2023

 

 

284,193

 

 

$

34.62

 

 

 

 

 

$

 

(1)
Includes adjustments for estimated achievement of performance-based criteria.
Summary of Activity of the Outstanding Restricted Stock Awards And Restricted Stock Units

The following table summarizes the activity of the outstanding restricted stock awards and restricted stock units:

 

 

Equity-Based
Restricted Stock Awards

 

 

Equity-Based
Restricted Stock Units

 

 

Liability-Based
Restricted Stock Units

 

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-Average
Grant Date
Fair Value

 

Balance at December 31, 2022

 

 

23,292

 

 

$

54.03

 

 

 

412,019

 

 

$

33.43

 

 

 

2,260

 

 

$

54.75

 

Granted

 

 

 

 

$

 

 

 

227,891

 

 

$

28.96

 

 

 

 

 

$

 

Vested

 

 

(23,011

)

 

$

54.20

 

 

 

(160,578

)

 

$

33.49

 

 

 

(2,260

)

 

$

54.75

 

Forfeited

 

 

(11

)

 

$

56.23

 

 

 

(30,339

)

 

$

32.92

 

 

 

 

 

$

 

Balance at December 31, 2023

 

 

270

 

 

$

39.28

 

 

 

448,993

 

 

$

31.18

 

 

 

 

 

$

 

Summary of Options Outstanding and Exercisable

The following table summarizes stock options outstanding and exercisable as of December 31, 2023:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of exercise prices

 

Shares

 

 

Weighted-Average
Remaining Contractual Life
(in years)

 

 

Weighted-Average
Exercise Price

 

 

Shares

 

 

Weighted-Average
Exercise Price

 

$21.85

 

 

54,150

 

 

 

3.65

 

 

$

21.85

 

 

 

54,150

 

 

$

21.85

 

$33.96

 

 

233,970

 

 

 

5.15

 

 

$

33.96

 

 

 

77,991

 

 

$

33.96

 

$44.80

 

 

137,858

 

 

 

4.15

 

 

$

44.80

 

 

 

91,906

 

 

$

44.80

 

$21.85 - $44.80

 

 

425,978

 

 

 

4.64

 

 

$

35.93

 

 

 

224,047

 

 

$

35.48

 

The aggregate intrinsic value of stock options outstanding at December 31, 2023 was $1.3 million, which represents the difference between our closing stock price at the end of the reporting period and the exercise price, multiplied by the number of in-the-money stock options. The aggregate intrinsic value of options exercisable at December 31, 2023 was $1.0 million